iNtRON Biotechnology, Inc. (048530.KQ)

KRW 5500.0

(-4.35%)

Inventory Summary of iNtRON Biotechnology, Inc.

iNtRON Biotechnology, Inc.'s latest annual inventory in 2023 was 1.01 Billion KRW , up 26.33% from previous year.
iNtRON Biotechnology, Inc.'s latest quarterly inventory in 2024 Q2 was 1.13 Billion KRW , up 23.88% from previous quarter.
iNtRON Biotechnology, Inc. reported annual inventory of 800.39 Million KRW in 2022, down -20.15% from previous year.
iNtRON Biotechnology, Inc. reported annual inventory of 1 Billion KRW in 2021, down -34.56% from previous year.
iNtRON Biotechnology, Inc. reported quarterly inventory of 918.2 Million KRW for 2024 Q1, down -9.19% from previous quarter.
iNtRON Biotechnology, Inc. reported quarterly inventory of 1.06 Billion KRW for 2023 Q3, up 43.66% from previous quarter.

Annual Inventory Chart of iNtRON Biotechnology, Inc. (2023 - 2012)

Historical Annual Inventory of iNtRON Biotechnology, Inc. (2023 - 2012)

Year	Inventory	Inventory Growth
2023	1.01 Billion KRW	26.33%
2022	800.39 Million KRW	-20.15%
2021	1 Billion KRW	-34.56%
2020	1.53 Billion KRW	13.78%
2019	1.34 Billion KRW	-7.84%
2018	1.46 Billion KRW	24.95%
2017	1.16 Billion KRW	6.4%
2016	1.09 Billion KRW	15.4%
2015	952.18 Million KRW	0.0%
2012	990.81 Million KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.13 Billion KRW	23.88%
2024 Q1	918.2 Million KRW	-9.19%
2023 Q3	1.06 Billion KRW	43.66%
2023 Q1	894.3 Million KRW	11.73%
2023 FY	1.01 Billion KRW	26.33%
2023 Q2	741.94 Million KRW	-17.04%
2023 Q4	1.01 Billion KRW	-5.14%
2022 FY	800.39 Million KRW	-20.15%
2022 Q4	800.39 Million KRW	-12.3%
2022 Q3	912.61 Million KRW	-8.64%
2022 Q2	998.95 Million KRW	-3.82%
2022 Q1	1.03 Billion KRW	3.62%
2021 Q3	930.51 Million KRW	-53.88%
2021 Q4	1 Billion KRW	7.72%
2021 FY	1 Billion KRW	-34.56%
2021 Q1	1.53 Billion KRW	-0.07%
2021 Q2	2.01 Billion KRW	31.82%
2020 FY	1.53 Billion KRW	13.78%
2020 Q1	1.41 Billion KRW	5.16%
2020 Q4	1.53 Billion KRW	-58.1%
2020 Q3	3.65 Billion KRW	-17.32%
2020 Q2	4.42 Billion KRW	212.34%
2019 Q3	1.55 Billion KRW	3.5%
2019 FY	1.34 Billion KRW	-7.84%
2019 Q1	1.47 Billion KRW	0.7%
2019 Q4	1.34 Billion KRW	-13.25%
2019 Q2	1.49 Billion KRW	1.93%
2018 Q4	1.46 Billion KRW	-13.33%
2018 FY	1.46 Billion KRW	24.95%
2018 Q3	1.68 Billion KRW	-1.15%
2018 Q2	1.7 Billion KRW	28.03%
2018 Q1	1.33 Billion KRW	13.91%
2017 Q1	998.67 Million KRW	-9.12%
2017 FY	1.16 Billion KRW	6.4%
2017 Q4	1.16 Billion KRW	-4.78%
2017 Q3	1.22 Billion KRW	5.16%
2017 Q2	1.16 Billion KRW	16.91%
2016 Q4	1.09 Billion KRW	0.0%
2016 Q1	- KRW	0.0%
2016 FY	1.09 Billion KRW	15.4%
2015 FY	952.18 Million KRW	0.0%
2013 Q3	885.69 Million KRW	-5.49%
2013 Q2	937.17 Million KRW	-0.87%
2013 Q1	945.36 Million KRW	-4.59%
2012 FY	990.81 Million KRW	0.0%
2012 Q4	990.81 Million KRW	15.83%
2012 Q3	855.43 Million KRW	0.0%

Peer Inventory Comparison of iNtRON Biotechnology, Inc.

Name	Inventory	Inventory Difference
HLB Co., Ltd.	11.42 Billion KRW	91.147%
BINEX Co., Ltd.	28.26 Billion KRW	96.422%
Bioneer Corporation	41.35 Billion KRW	97.555%
Anterogen.Co.,Ltd.	1.91 Billion KRW	47.077%
MEDIPOST Co., Ltd.	14.51 Billion KRW	93.035%
CrystalGenomics, Inc.	1.55 Billion USD	34.969%
Helixmith Co., Ltd	914.11 Million KRW	-10.61%
Chabiotech Co.,Ltd.	34.11 Billion KRW	97.036%
Medy-Tox Inc.	59.61 Billion KRW	98.304%
Peptron, Inc.	172.18 Million KRW	-487.212%
Amicogen, Inc.	46.83 Billion KRW	97.841%
Genexine, Inc.	3.8 Billion KRW	73.44%
HLB Therapeutics Co.,Ltd.	5.33 Billion KRW	81.051%
LegoChem Biosciences, Inc.	196.83 Million KRW	-413.683%
ALTEOGEN Inc.	1.06 Billion KRW	5.359%
PharmaResearch Co., Ltd.	50.23 Billion KRW	97.987%
SillaJen, Inc.	1.21 Billion KRW	16.619%
JETEMA, Co., Ltd.	12.74 Billion KRW	92.064%
OliX Pharmaceuticals,Inc	468.4 Million KRW	-115.859%
Genomictree Inc.	496.53 Million KRW	-103.633%
MedPacto, Inc.	620.00 KRW	-163081235.161%
D&D Pharmatech	3.45 Billion KRW	70.694%
EASY BIO,Inc.	25.93 Billion KRW	96.102%
GI Innovation, Inc.	- KRW	-Infinity%